For citations:
Prilutskiy A.S., Prilutskaia O.A. Use of omalizumab and allergen-specific immunotherapy for the treatment of respiratory allergic diseases in children and adults. Allergology and Immunology in Paediatrics. 2024;(2):38-49. (In Russ.) https://doi.org/10.53529/2500-1175-2024-2-38-49